AMY CLARK: Open Payments
NPI 1265969356 · SHEBOYGAN, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,173 in 25 payments from 17 companies in 2025. Trend: 2023 $863 · 2024 $1,361 · 2025 $1,173
Food & beverage: $759Education: $414
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $348 |
| Astellas Pharma US Inc | 2 | $195 |
| PFIZER INC. | 2 | $151 |
| SEAGEN INC. | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| ABBVIE INC. | 2 | $55 |
| JAZZ PHARMACEUTICALS INC. | 1 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Alexion Pharmaceuticals, Inc. | 1 | $30 |
| Eisai Inc. | 1 | $28 |
Products named: BRAFTOVI, Trodelvy, ZIIHERA, ULTOMIRIS, EMRELIS, Lenvima, Zoladex, ELAHERE.
Industry payments across WI — which companies pay providers there.
